4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-000599
Chief Executive Officer acquired 892,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolan Sean P. Chief Executive Officer | 2025-01-02 | Grant or award | +892,500 | 2,078,358 | D | ||
| Derivatives | |||||||
| Nolan Sean P. Chief Executive Officer | 2025-01-02 | Grant or award · Employee Stock Option (right to buy) | +892,500 | 892,500 | D | ||
Loading xslF345X05/form4-01032025_100137.xml…